EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced

Wei He, Qi Geng, Guiying Ji, Ji Li, Dan Wang, Yucai He iD, Qiuheng Jin iD, Jianren Ye

Molecules · 2024

DOI: 10.3390/molecules29194713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Wei He und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Forestry, Nanjing Forestry University, Nanjing 210037, China. Hauptthemen laut MEDLINE: RNA, Messenger, DNA-Directed RNA Polymerases, Transcription, Genetic, Viral Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The remarkable efficacy of COVID-19 vaccines has established mRNA as a highly promising biomedical technology. However, the adequate application of mRNA therapeutics necessitates additional measures to mitigate the inherent immunogenicity, which is predominantly caused by dsRNA. As a byproduct of the in vitro transcription of mRNA, dsRNA was reported to be originated through several distinct mechanisms, including the extension of 3′ loop-back hairpins, the extension of hybridized abortive transcripts, and promoter-independent transcription. The intricate mechanisms involved pose a dilemma as the reduction in dsRNA results in a concomitant decrease in other critical quality attributes of mRNA. Here, we demonstrate that the promoter binding motifs of T7 RNA polymerase directly impact the production of promoter-independent transcription-based dsRNA. Specifically, the G753A mutation significantly reduces the formation of dsRNA byproducts, which can further combine with modified nucleotides to enhance the effectiveness of dsRNA mitigation and with previously reported high-integrity mutation K389A to minimize side effects. Accordingly, the present study reports a cost-effective approach to synthesize high-purity, less immunostimulatory mRNA by using an engineered T7 RNA polymerase mutant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerDNA-Directed RNA PolymerasesTranscription, GeneticViral ProteinsSARS-CoV-2HumansCOVID-19 VaccinesPromoter Regions, GeneticMutationRNA, Double-StrandedCOVID-19

Stichwörter der Autor:innen

dsRNAimpuritiesin vitro transcriptionmRNAmRNA integrity

Substanzen

bacteriophage T7 RNA polymeraseRNA, MessengerDNA-Directed RNA PolymerasesViral ProteinsCOVID-19 VaccinesRNA, Double-Stranded

Autor:innen und Institutionen

  • College of Forestry, Nanjing Forestry University, Nanjing 210037, China.
  • Vazyme Biotech Co., Ltd., Nanjing 210037, China.
  • School of Pharmacy, Changzhou University, Changzhou 213164, China.

ORCID-Profile: Yucai He, Qiuheng Jin

Zitieren

APA

He, W., Geng, Q., Ji, G., Li, J., Wang, D., He, Y., Jin, Q., & Ye, J. (2024). Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced. Molecules. https://doi.org/10.3390/molecules29194713

Vancouver

He W, Geng Q, Ji G, Li J, Wang D, He Y, et al. Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced. Molecules. 2024. doi:10.3390/molecules29194713

BibTeX
@article{He2024,
  author = {He, Wei and Geng, Qi and Ji, Guiying and Li, Ji and Wang, Dan and He, Yucai and Jin, Qiuheng and Ye, Jianren},
  title = {Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29194713}
}
Kostenlos starten →